PROSHARES TRUST (ZBIO) Leases: 2023-2025
Historic Leases for Zenas BioPharma (ZBIO) over the last 1 years, with Sep 2025 value amounting to $807,000.
- Zenas BioPharma's Leases rose 102.26% to $807,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $807,000, marking a year-over-year increase of 102.26%. This contributed to the annual value of $1.0 million for FY2024, which is 22.29% up from last year.
- Per Zenas BioPharma's latest filing, its Leases stood at $807,000 for Q3 2025, which was down 20.10% from $1.0 million recorded in Q2 2025.
- In the past 5 years, Zenas BioPharma's Leases ranged from a high of $1.2 million in Q1 2025 and a low of $399,000 during Q3 2024.
- In the last 3 years, Zenas BioPharma's Leases had a median value of $912,500 in 2023 and averaged $874,167.
- Data for Zenas BioPharma's Leases shows a peak YoY skyrocketed of 102.26% (in 2025) over the last 5 years.
- Zenas BioPharma's Leases (Quarterly) stood at $821,000 in 2023, then climbed by 22.29% to $1.0 million in 2024, then soared by 102.26% to $807,000 in 2025.
- Its last three reported values are $807,000 in Q3 2025, $1.0 million for Q2 2025, and $1.2 million during Q1 2025.